在应用脂微球前列地尔E1治疗膈疝期间动脉导管瘤样扩张。
Aneurysmal dilatation of ductus arteriosus during lipo-prostaglandin E1 therapy for diaphragmatic hernia.
作者信息
Tohyama M, Baba A, Tsuno T, Aonuma K, Komiyama A
机构信息
Department of Paediatrics, Shinshu University, Matsumoto, Japan.
出版信息
Eur J Pediatr. 1993 Nov;152(11):877-9. doi: 10.1007/BF01957520.
We report a case of congenital diaphragmatic hernia in which aneurysmal dilatation of ductus arteriosus developed after lipo-prostaglandin E1 (PGE1) therapy for persistent fetal circulation. After surgery Lipo-PGE1 was used at a dosage of 5 ng/kg per minute from days 2-9 during which aneurysmal dilatation (7 mm in diameter) developed and remained thereafter. Ductus arteriosus ligation was then performed. Lipo-PGE1 may promote ductus arteriosus dilatation in cases of persistent fetal circulation.
我们报告了一例先天性膈疝病例，该病例在使用脂微球前列腺素E1（PGE1）治疗持续性胎儿循环后出现动脉导管瘤样扩张。术后，从第2天至第9天以每分钟5 ng/kg的剂量使用脂微球PGE1，在此期间出现了动脉导管瘤样扩张（直径7 mm），之后持续存在。随后进行了动脉导管结扎术。脂微球PGE1在持续性胎儿循环病例中可能会促进动脉导管扩张。
Zotero 插件